Three-quarters of those surveyed said the program’s resources helped reduce unwanted physical side effects, and more than 80% said it lessened at least one aspect of financial stress. Overall, 85% ...

The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release ...

The U.K. is upholding its end of a recent trade deal with the U.S., increasing the island country’s potential spending on new medicines by cutting the rebates paid by pharma companies under a ...

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...

Supreme Group has consolidated two of the companies it bought during a nine-deal, 18-month splurge, combining Amendola ...

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. | Pfizer has rolled out detailed trial ...

While many headline-grabbing biologics and advanced therapeutics like cell and gene therapies are approved as injectables, ...

With a new edition of a long-running awareness campaign, Genentech is drawing attention to the talents and passions that are ...

The new Lilly facilities—which include a $5 billion API plant near Richmond, Virginia, which was announced in September—are ...

Viatris is letting go of the equity stake it’s held in Biocon’s biosimilar subsidiary Biocon Biologics for $815 million, allowing Biocon to fully integrate its subsidiary. | Returning its stake in ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...